Ahmed Bahie Eldeen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ahmed Bahie Eldeen has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
Alaa Sabry
1 shared publication- Alaa Sabry
Mansoura Urology and Nephrology Center, Mansoura University, Mansoura, Egypt
1 shared publication Mohamad Elrefai
1 shared publication- Mohamad Elrefai
Gastrointestinal Surgical Center, Department of Surgery, Faculty of Medicine, Mansoura University, Al Mansurah, Egypt.
1 shared publication Shimaa Monir
1 shared publication- Shimaa Monir Elmamlook
Ministry of Health, Aga Central Hospital, Aga, Egypt
1 shared publication
Latest Publications
- Open Access
- 9 January 2024
- Published by Springer Nature in Obesity Surgery
- Vol. 34 (2) , 610-617
Effect of Sleeve Gastrectomy Versus One Anastomosis Gastric Bypass on Postoperative Renal Function and the Urinary Monocyte Chemoattractant Protein-1 (MCP-1) Level
Introduction: Bariatric surgery has been the most effective treatment modality for morbid obesity that reduces associated comorbidities and improves quality of life. This study aims at evaluating and comparing the impact of two types of bariatric surgery—laparoscopic sleeve gastrectomy (LSG) and one anastomosis gastric bypass (OAGB)—on renal functions and urinary monocyte chemoattractant protein-1 (MPC-1) levels in morbidly obese patients 3 months after surgery. Methods: This is a prospective study of 40 morbidly obese patients who underwent bariatric surgery. Two types of bariatric surgery were done—laparoscopic sleeve gastrectomy (LSG) (26 patients) and laparoscopic one anastomosis gastric bypass (OAGB) (14 patients). The outcomes of the two procedures were compared in terms of renal function parameters and the level of urinary MCP-1. Results: There were no statistically significant differences in the mean postoperative urinary MCP-1 (73.53 ± 21.25, 75.43 ± 26.17, P > 0.5), microalbuminuria (8.83 ± 6.26, 10.02 ± 8.6, P > 0.05), urinary creatinine (109.21 ± 43.22, 99.19 ± 48.65, P > 0.05), MCP1/Cr ratio (0.78 ± 0.36, 1.01 ± 0.70, P > 0.05), eGFR (100.32 ± 9.54, 104.39 ± 9.54, P > 0.05) in the cases who had either LSG operation or OAGB operation. Conclusion: Bariatric surgery improves all indicators of kidney malfunction and reduces the level of urinary MCP-1. Both laparoscopic sleeve gastrectomy (LSG) and laparoscopic one anastomosis gastric bypass (OAGB) cause similar improvement of the renal function and reduction of urinary MCP-1 level. Graphical
- 9 January 2024
- Published by Springer Nature in Obesity Surgery
- Vol. 34 (2) , 610-617
Open AccessEffect of Sleeve Gastrectomy Versus One Anastomosis Gastric Bypass on Postoperative Renal Function and the Urinary Monocyte Chemoattractant Protein-1 (MCP-1) Level
Introduction: Bariatric surgery has been the most effective treatment modality for morbid obesity that reduces associated comorbidities and improves quality of life. This study aims at evaluating and comparing the impact of two types of bariatric surgery—laparoscopic sleeve gastrectomy (LSG) and one anastomosis gastric bypass (OAGB)—on renal functions and urinary monocyte chemoattractant protein-1 (MPC-1) levels in morbidly obese patients 3 months after surgery. Methods: This is a prospective study of 40 morbidly obese patients who underwent bariatric surgery. Two types of bariatric surgery were done—laparoscopic sleeve gastrectomy (LSG) (26 patients) and laparoscopic one anastomosis gastric bypass (OAGB) (14 patients). The outcomes of the two procedures were compared in terms of renal function parameters and the level of urinary MCP-1. Results: There were no statistically significant differences in the mean postoperative urinary MCP-1 (73.53 ± 21.25, 75.43 ± 26.17, P > 0.5), microalbuminuria (8.83 ± 6.26, 10.02 ± 8.6, P > 0.05), urinary creatinine (109.21 ± 43.22, 99.19 ± 48.65, P > 0.05), MCP1/Cr ratio (0.78 ± 0.36, 1.01 ± 0.70, P > 0.05), eGFR (100.32 ± 9.54, 104.39 ± 9.54, P > 0.05) in the cases who had either LSG operation or OAGB operation. Conclusion: Bariatric surgery improves all indicators of kidney malfunction and reduces the level of urinary MCP-1. Both laparoscopic sleeve gastrectomy (LSG) and laparoscopic one anastomosis gastric bypass (OAGB) cause similar improvement of the renal function and reduction of urinary MCP-1 level. Graphical
- Open Access
- 1 January 2024
- Published by Medknow in Journal of The Egyptian Society of Nephrology and Transplantation
- Vol. 24 (1) , 29
Study of urinary monocyte chemoattractant protein-1(MCP-1) level in severely obese patients before and after bariatric surgeries and its relation to renal function
Omorbidities, physiological abnormalities and immune impairments. In the long term, bariatric surgery protects against renal function decline in obese patients. The objectives of this study is to assess the level of renal inflammatory marker urinary monocyte chemoattractant protein -1(MCP-1), measure the urinary MCP-1 to urinary creatinine concentration ratio in severely obese patients before and after bariatric surgeries. To study if there any possible relation between the urinary MCP-1 levels and renal function before and after surgery. Materials and Methods This prospective study of 40 severely obese patients undergoing bariatric surgery were recruited in the study in the interval between October 2018 and July 2019. Evaluate the level of MCP-1, urinary creatinine, urinary albumin, glomerular filtration rate (GFR), body weight, BMI, C-reactive protein (CRP), serum albumin, blood pressure and lipid profile before and after three months of bariatric surgeries. Results The mean urinary level of MCP-1 preoperative was 105.19 ± 15.25 pg/ml (range between 75.41 and 131.67) and this level was decreased postoperatively to 74.20 ± 22.77 (range between 30.5 and 114.4) with high statistically significant difference (P < 0.001). While urinary MCP-1/creatinine ratio; the bariatric surgery significantly reduced the mean of urinary MCP-1/creatinine ratios from 2.08 ± 1.43 to 0.86 ± 0.51 (P < 0.001). Also, there were significant improvement of blood pressure, C-reactive protein, lipid profile and body mass index three months after bariatric surgery. Conclusion Urinary MCP-1 levels following bariatric surgery can be used as potential marker to the ongoing renal inflammatory process....
- 1 January 2024
- Published by Medknow in Journal of The Egyptian Society of Nephrology and Transplantation
- Vol. 24 (1) , 29
Open AccessStudy of urinary monocyte chemoattractant protein-1(MCP-1) level in severely obese patients before and after bariatric surgeries and its relation to renal function
Omorbidities, physiological abnormalities and immune impairments. In the long term, bariatric surgery protects against renal function decline in obese patients. The objectives of this study is to assess the level of renal inflammatory marker urinary monocyte chemoattractant protein -1(MCP-1), measure the urinary MCP-1 to urinary creatinine concentration ratio in severely obese patients before and after bariatric surgeries. To study if there any possible relation between the urinary MCP-1 levels and renal function before and after surgery. Materials and Methods This prospective study of 40 severely obese patients undergoing bariatric surgery were recruited in the study in the interval between October 2018 and July 2019. Evaluate the level of MCP-1, urinary creatinine, urinary albumin, glomerular filtration rate (GFR), body weight, BMI, C-reactive protein (CRP), serum albumin, blood pressure and lipid profile before and after three months of bariatric surgeries. Results The mean urinary level of MCP-1 preoperative was 105.19 ± 15.25 pg/ml (range between 75.41 and 131.67) and this level was decreased postoperatively to 74.20 ± 22.77 (range between 30.5 and 114.4) with high statistically significant difference (P < 0.001). While urinary MCP-1/creatinine ratio; the bariatric surgery significantly reduced the mean of urinary MCP-1/creatinine ratios from 2.08 ± 1.43 to 0.86 ± 0.51 (P < 0.001). Also, there were significant improvement of blood pressure, C-reactive protein, lipid profile and body mass index three months after bariatric surgery. Conclusion Urinary MCP-1 levels following bariatric surgery can be used as potential marker to the ongoing renal inflammatory process....